Private company

BioPlus Acquisition Corp.

Last updated Oct 16, 2026.

Overview

$2.0MNet income, fiscal 2022²

IndustryElectromedical & Electrotherapeutic Apparatus
HeadquartersE9
Incorporated inCayman Islands³
Business address260 Madison Avenue, Suite 800, New York, Ny 10016³
Filer category, Emerging growth company³

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Fiscal year	2021	2022
Operating income		-$1.2M²
Net income		$2.0M²

Total assets²$238.3M in 2022+1% since 2021

Total liabilities²$15.3M in 2022+2% since 2021

Shareholders’ equity²-$14.8M in 2022+9% since 2021

Cash⁶²$140.3K in 2022−78% since 2021

Fiscal year	2021	2022
Cash	$635.5K⁶	$140.3K²
Current assets	$1.0M²	$548.8K²
Total assets	$236.0M²	$238.3M²
Current liabilities	$179.1K²	$526.9K²
Total liabilities	$15.0M²	$15.3M²
Shareholders’ equity	-$13.6M²	-$14.8M²

Compare BioPlus Acquisition Corp. with another company

Recent filings

Oct 4, 20238-K CURRENT REPORT
Aug 14, 202310-Q
Jun 14, 20238-K
Jun 12, 20234 FORM 4 SUBMISSION
Jun 8, 20238-K
May 30, 20238-K
May 15, 202310-Q
May 12, 2023DEF 14A
May 3, 20238-K
Mar 31, 202310-K
Nov 3, 202210-Q
Oct 11, 20228-K
Aug 10, 202210-Q
May 12, 202210-Q
Mar 11, 202210-K

Every filing from the last three years, summarized. The full record is on SEC EDGAR.¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARBioPlus Acquisition Corp. filings on SEC EDGAR
2
SEC EDGARBioPlus Acquisition Corp. 10-K for fiscal 2022
3
SEC EDGARBioPlus Acquisition Corp. filings on SEC EDGAR
4
SEC EDGARBioPlus Acquisition Corp. 10-Q for fiscal 2023
5
SEC EDGARBioPlus Acquisition Corp. 10-Q for fiscal 2023
6
SEC EDGARBioPlus Acquisition Corp. 10-K for fiscal 2021